Vous êtes ici

1CM Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
EPIC
Indice CSE: 
Devise: 

1CM Inc. concentrates on non-psychoactive hemp derived products for the health and wellness market. The Company’s global capabilities position it to become a leading multi-jurisdictional cannabinoid producer – one that brings together the best cannabinoid products, brands and expertise from Canada and around the world. The 1CM portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis/hemp sector; Leviathan US Inc., which is manufacturing cannabinoid products from its facility in Smith County, Tennessee; LCG Holdings Inc., which intends to build a facility and cultivate hemp and manufacture cannabidiol extracted products in Carmen de Viboral, Colombia; and Woodstock Biomed Inc., which owns a 30-acre property with greenhouse infrastructure in Pelham, Ontario. The Woodstock property operates under a lease agreement with Medical Saints Ltd., a Health Canada regulated licensed producer of industrial hemp. 

Vous êtes ici

1CM Inc. (EPIC)

SEDAR Information

Information d'entreprise

Addresse
625 Cochrane Dr, Markham, ON, L3R 9R9
Suite 802
Markham, ON L3R 9R9
Canada
Téléphone
717-888-8889
Courriel
info@Leviathan-Naturals.com
URL
http://www.Leviathan-Naturals.com
Date d’inscription à la cote
Mardi, janvier 23, 2018
Agent de transfert
Computershare Investor Services Inc.
Courriel
info@Leviathan-Naturals.com

Advertisement

Publicité

Capitalisation

Capitalisation: 
114,403,602
Réservé à l'émission: 
3,825,000

Company Officers

Tanvi Bhandari, CEO
Harshil Chovatiya, COO
Linda Marabeti Romano, CFO

Bulletins

13/09/2022

2022-0917 - Changement de Nom - Leviathan Natural Products Inc. (EPIC)

Le 13 septembre/September 2022

Leviathan Natural Products Inc. has announced a name change to 1CM Inc.

Shares will begin trading under the new name and with a new CUSIP number on September 14, 2022.

The symbol will remain the same.

Disclosure documents are available at www.thecse.com

Advertisement

Publicité

Latest CSE News